gerald

AMA Update 124: The FDA on Paxlovid and COVID-19: What physicians need to know, Part II

15 de febrero de 2022 casimedicos 00:14:49 0 Comments

In part two of this three-part series, Stephanie Troy, MD, senior medical officer, Division of Antivirals, Office of Infectious Disease in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA, discusses what to know about Paxlovid as treatment for COVID-19.

AMA Update 123: The FDA on Monoclonal Antibody Therapeutics: What physicians need to know, Part I

11 de febrero de 2022 casimedicos 00:10:04 0 Comments

AMA president Gerald Harmon, MD, welcomes experts from the U.S. Food and Drug Administration (FDA) to discuss what prescribers need to know about COVID-19 therapeutic drugs, Paxlovid and Molnupiravir. Alternative treatment options for high-risk outpatients with mild-moderate COVID-19 are also discussed.

Guest: John Farley, MD, MPH, director, Office of Infectious Diseases in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA